ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 148 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,233,027 | +13.7% | 60,177 | +10.3% | 0.22% | +15.4% |
Q2 2023 | $1,084,286 | +16.7% | 54,569 | +0.6% | 0.19% | +12.6% |
Q1 2023 | $928,994 | -12.6% | 54,232 | -0.2% | 0.17% | -12.6% |
Q4 2022 | $1,063,121 | +17.0% | 54,324 | -4.6% | 0.19% | +5.5% |
Q3 2022 | $909,000 | +9.3% | 56,951 | -5.8% | 0.18% | +13.8% |
Q2 2022 | $832,000 | +20.2% | 60,475 | +38.5% | 0.16% | +43.2% |
Q1 2022 | $692,000 | -13.1% | 43,655 | +19.8% | 0.11% | -5.1% |
Q4 2021 | $796,000 | -29.5% | 36,449 | -3.5% | 0.12% | -32.4% |
Q3 2021 | $1,129,000 | -31.8% | 37,782 | +1.1% | 0.17% | -28.8% |
Q2 2021 | $1,655,000 | +28.4% | 37,360 | +28.6% | 0.24% | +20.3% |
Q1 2021 | $1,289,000 | -31.8% | 29,061 | -15.7% | 0.20% | -35.3% |
Q4 2020 | $1,890,000 | +69.5% | 34,464 | -29.4% | 0.31% | +52.2% |
Q3 2020 | $1,115,000 | +9.6% | 48,795 | +0.4% | 0.20% | +6.8% |
Q2 2020 | $1,017,000 | +29.1% | 48,577 | -14.0% | 0.19% | +10.3% |
Q1 2020 | $788,000 | +15.2% | 56,458 | +87.8% | 0.17% | +47.5% |
Q4 2019 | $684,000 | – | 30,058 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |